Cutting-Edge CAR Engineering: Beyond T Cells

Chimeric antigen receptor (CAR)-T adoptive cell therapy is one of the most promising advanced therapies for the treatment of cancer, with unprecedented outcomes in haematological malignancies. However, it still lacks efficacy in solid tumours, possibly because engineered T cells become inactive with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chocarro, Luisa, Blanco, Ester, Fernández-Rubio, Leticia, Arasanz, Hugo, Bocanegra, Ana, Echaide, Miriam, Garnica, Maider, Ramos, Pablo, Piñeiro-Hermida, Sergio, Vera, Ruth, Kochan, Grazyna, Escors, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776293/
https://www.ncbi.nlm.nih.gov/pubmed/36551788
http://dx.doi.org/10.3390/biomedicines10123035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776293/
https://www.ncbi.nlm.nih.gov/pubmed/36551788
http://dx.doi.org/10.3390/biomedicines10123035

Ejemplares similares